Gilead Sciences Inc

GILD 
(NASDAQ) 
 
$ 62.51 <%= Resources.Global.txtDown %>
Updated 22/08/2019
Change % -2.66% Stock price decreasing
Change -1.71 Stock price decreasing
Volume 4,994,533
High $ 64.67
Low $ 62.19
Open $ 64.07
ISIN
Prev close $ 64.22
# of shares 1,266.46M
Market cap 79,166M USD
Intraday

Market closed
Gilead Sciences Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  62.51 -1.0% Stock price decreasing -5.7% Stock price decreasing -6.5% Stock price decreasing -4.3% Stock price decreasing -15.1% Stock price decreasing
Powered by TradingView

News about Gilead Sciences Inc

  • English
  • Regulatory news

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Abbott Laboratories 81.93 -3.4% Stock price decreasing -6.9% Stock price decreasing 6.4% Stock price increasing 6.6% Stock price increasing 23.9% Stock price increasing 13.3% Stock price increasing
 
Bristol-Myers Squibb Company 46.58 -0.9% Stock price decreasing 2.6% Stock price increasing -0.5% Stock price decreasing -8.0% Stock price decreasing -22.3% Stock price decreasing -10.4% Stock price decreasing
 
Merck & Company Inc (new) 84.94 -0.1% Stock price decreasing 3.9% Stock price increasing 4.6% Stock price increasing 5.7% Stock price increasing 23.0% Stock price increasing 11.2% Stock price increasing
 
Pfizer Inc 34.34 -0.9% Stock price decreasing -19.5% Stock price decreasing -18.1% Stock price decreasing -20.3% Stock price decreasing -19.0% Stock price decreasing -21.3% Stock price decreasing
 
Amgen Inc 199.08 -2.4% Stock price decreasing 14.3% Stock price increasing 16.2% Stock price increasing 4.9% Stock price increasing 1.2% Stock price increasing 2.3% Stock price increasing
 
Celgene Corporation 93.99 -0.8% Stock price decreasing 2.0% Stock price increasing -1.3% Stock price decreasing 4.0% Stock price increasing 4.5% Stock price increasing 46.7% Stock price increasing
 
Glaxosmithkline PLC ORD 25P 1,691.20 2.0% Stock price increasing 1.3% Stock price increasing 6.9% Stock price increasing 10.2% Stock price increasing 5.5% Stock price increasing 13.4% Stock price increasing
 
Sanofi 76.73 1.0% Stock price increasing 1.8% Stock price increasing 2.1% Stock price increasing 5.5% Stock price increasing 2.7% Stock price increasing 1.4% Stock price increasing
 
Novartis N 87.34 -0.2% Stock price decreasing -4.5% Stock price decreasing 0.1% Stock price increasing 8.3% Stock price increasing 20.1% Stock price increasing 17.6% Stock price increasing
 
Roche GS 271.85 -0.5% Stock price decreasing 2.8% Stock price increasing 0.2% Stock price increasing -1.6% Stock price decreasing 12.8% Stock price increasing 11.7% Stock price increasing
 
Biogen Inc 225.85 -2.5% Stock price decreasing -5.2% Stock price decreasing -0.5% Stock price decreasing -31.0% Stock price decreasing -34.0% Stock price decreasing -24.9% Stock price decreasing
 
Roche Holding AG Roche Holding.. 271.85 -0.5% Stock price decreasing 1.6% Stock price increasing 0.0% Stock price decreasing -1.8% Stock price decreasing 12.6% Stock price increasing 12.7% Stock price increasing

Company profile

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite acquisition boosted Gilead's exposure to cell therapy in oncology.

Peers

Instruments Last Change  
Abbott Labor.. 81.93 -2.9% Stock price decreasing
Bristol-Myer.. 46.58 -2.7% Stock price decreasing
Merck & Comp.. 84.94 -2.1% Stock price decreasing
Pfizer Inc 34.34 -2.1% Stock price decreasing
Amgen Inc 199.08 -2.1% Stock price decreasing
76,86,89,19,15,10,27,22,25,23
Celgene Corp.. 93.99 -1.8% Stock price decreasing
Glaxosmithkl.. 1,691.20 0.9% Stock price increasing
Sanofi 76.73 -0.4% Stock price decreasing
Novartis N 87.34 -0.5% Stock price decreasing
42,90,84,89,91,38,46,66,58,9
Roche GS 271.85 0.0% Stock price decreasing
16,80,77,90,97,43,42,71,78,7
Biogen Inc 225.85 -2.7% Stock price decreasing
Roche Holdin.. 271.85 0.0% Stock price decreasing

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 August 2019 00:11:04
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB5 - 2019-08-25 01:11:04 - 2019-08-25 00:11:04 - 1000 - Website: OKAY